Scandion Oncology A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, net loss was DKK 18.06 million compared to DKK 35.94 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 SEK | +2.58% | +5.30% | -65.21% |
1st Jan change | Capi. | |
---|---|---|
-65.21% | 5.09M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |